Altered responsiveness of metastatic versus non-metastatic fibroblasts to heparin-binding growth factors.
Cells may become more metastatic partially by gaining growth factor autonomy. This hypothesis was examined by investigating the effects on DNA synthesis of a novel hepatic heparin-binding growth factor (HBGF), and of the well-characterized HBGF, basic fibroblast growth factor (bFGF), using cells of varying metastatic potential. Cells were rendered metastatic by transfection of parental 10T 1/2 fibroblasts with the T24-H-ras oncogene. Both HBGFs stimulated DNA synthesis 2.0-11.1 fold in 10T 1/2 cells in the presence of alpha-minimal essential medium containing 10% fetal bovine serum. In contrast, cells of intermediate metastatic potential or of high metastatic potential, were inhibited approximately 2-fold by the hepatic HBGF, and did not respond to bFGF in alpha-minimal essential medium plus 10% fetal bovine serum. This lack of stimulation was converted to an enhancement of DNA synthesis in the absence of serum when using metastatic but not non-metastatic cells. This is the first demonstration that metastatic cells have a significantly altered responsiveness to these growth factors as compared to non-metastatic parental cells, and indicates that these modifications may play a role in a mechanism of tumor progression.